Expanding indications for TAVI - moderate aortic stenosis and heart failure

Spokesperson: K. Poon
SHOW MORE

Summary

Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.

You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how they impact patient selection), learn how to diagnose moderate AS accurately, stratify risk and determine who could benefit from early TAVI.

Learning Objectives

  • To discuss the potential benefits of early intervention in patients with moderate aortic stenosis and heart failure
  • To appreciate the key considerations that determine the accurate diagnosis of moderate aortic stenosis
  • To understand how to stratify patients with moderate aortic stenosis based upon the future risk of cardiac damage

Presentations available when logged in:

  • Welcome and session objectives
  • Trials on asymptomatic severe aortic stenosis (EARLY TAVR, EVOLVED)
  • What DO these trials tell us (and what they DO NOT)?
  • Trials on moderate aortic stenosis and heart failure (TAVR UNLOAD, PROGRESS, EXPAND TAVR II)
  • What DO these trials tell us (and what they DO NOT)